Kent MS - Search Results

1

MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.

Kent MS, Zwingenberger A, Westropp JL, Barrett LE, Durbin-Johnson BP, Ghosh P, Vinall RL. Kent MS, et al. BMC Vet Res. 2017 Nov 15;13(1):339. doi: 10.1186/s12917-017-1259-1. BMC Vet Res. 2017. PMID: 29141625 Free PMC article.

2

Computer-assisted image analysis of neovascularization in thyroid neoplasms from dogs.

Kent MS, Griffey SM, Verstraete FJ, Naydan D, Madewell BR. Kent MS, et al. Am J Vet Res. 2002 Mar;63(3):363-9. doi: 10.2460/ajvr.2002.63.363. Am J Vet Res. 2002. PMID: 11926179 Free article.

3

Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs.

Kent MS, Bommarito D, Feldman E, Theon AP. Kent MS, et al. J Vet Intern Med. 2007 Sep-Oct;21(5):1027-33. doi: 10.1892/0891-6640(2007)21[1027:snrapf]2.0.co;2. J Vet Intern Med. 2007. PMID: 17939560 Free article.

4

A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.

Grant IA, Rodriguez CO, Kent MS, Sfilgoi G, Gordon I, Davis G, Lord L, London CA. Grant IA, et al. Among authors: kent ms. J Vet Intern Med. 2008 Mar-Apr;22(2):388-93. doi: 10.1111/j.1939-1676.2008.0051.x. Epub 2008 Feb 28. J Vet Intern Med. 2008. PMID: 18312556 Free article. Clinical Trial.

5

Canine intraspinal meningiomas: imaging features, histopathologic classification, and long-term outcome in 34 dogs.

Petersen SA, Sturges BK, Dickinson PJ, Pollard RE, Kass PH, Kent M, Vernau KM, Lecouteur RA, Higgins RJ. Petersen SA, et al. J Vet Intern Med. 2008 Jul-Aug;22(4):946-53. doi: 10.1111/j.1939-1676.2008.0106.x. J Vet Intern Med. 2008. PMID: 18482277 Free article.

6

Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs.

Gordon IK, Ye F, Kent MS. Gordon IK, et al. Among authors: kent ms. Am J Vet Res. 2008 Aug;69(8):1079-84. doi: 10.2460/ajvr.69.8.1079. Am J Vet Res. 2008. PMID: 18672974 Free article.

7

Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines.

Kent MS, Collins CJ, Ye F. Kent MS, et al. Am J Vet Res. 2009 Feb;70(2):263-9. doi: 10.2460/ajvr.70.2.263. Am J Vet Res. 2009. PMID: 19231960 Free PMC article.

8

Canine malignant melanoma alpha-3 integrin binding peptides.

Aina OH, Maeda Y, Harrison M, Zwingenberger AL, Walker NJ, Lam KS, Kent MS. Aina OH, et al. Among authors: kent ms. Vet Immunol Immunopathol. 2011 Sep 15;143(1-2):11-9. doi: 10.1016/j.vetimm.2011.05.018. Epub 2011 May 19. Vet Immunol Immunopathol. 2011. PMID: 21722969 Free PMC article.

9

Development and characterization of 5 canine B-cell lymphoma cell lines.

Zwingenberger AL, Vernau W, Shi C, Yan W, Chen X, Gordon IK, Kent MS. Zwingenberger AL, et al. Among authors: kent ms. Leuk Res. 2012 May;36(5):601-6. doi: 10.1016/j.leukres.2011.11.004. Epub 2011 Dec 1. Leuk Res. 2012. PMID: 22136758 Free PMC article.

10

Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.

Zwingenberger AL, Kent MS, Shi C, Taylor SL, Chen X, Lam KS. Zwingenberger AL, et al. Among authors: kent ms. Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):298-304. doi: 10.1016/j.vetimm.2011.11.018. Epub 2011 Nov 25. Vet Immunol Immunopathol. 2012. PMID: 22177114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters